Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Reduced by Greenleaf Trust

Greenleaf Trust trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.3% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 25,252 shares of the medical equipment provider’s stock after selling 869 shares during the quarter. Greenleaf Trust’s holdings in Intuitive Surgical were worth $8,519,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. OFI Invest Asset Management bought a new stake in Intuitive Surgical in the 3rd quarter valued at about $25,000. Baystate Wealth Management LLC increased its stake in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 45 shares during the period. Headinvest LLC acquired a new position in shares of Intuitive Surgical during the third quarter worth approximately $28,000. Stone House Investment Management LLC grew its holdings in Intuitive Surgical by 100.0% in the 3rd quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 50 shares in the last quarter. Finally, Householder Group Estate & Retirement Specialist LLC bought a new position in Intuitive Surgical in the 3rd quarter worth approximately $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 1.7 %

ISRG stock traded down $6.29 during mid-day trading on Friday, reaching $366.34. 3,966,068 shares of the stock traded hands, compared to its average volume of 1,675,699. The stock’s fifty day moving average is $387.27 and its 200-day moving average is $342.60. The company has a market cap of $129.85 billion, a P/E ratio of 73.65, a P/E/G ratio of 5.81 and a beta of 1.36. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The firm had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same quarter last year, the business posted $1.00 EPS. The company’s revenue was up 11.5% on a year-over-year basis. Equities research analysts expect that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current year.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $370.15, for a total transaction of $1,598,307.70. Following the transaction, the executive vice president now owns 189 shares of the company’s stock, valued at approximately $69,958.35. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other news, Director Alan J. Levy sold 2,000 shares of the company’s stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.20, for a total value of $740,400.00. Following the transaction, the director now directly owns 25,319 shares of the company’s stock, valued at $9,373,093.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,318 shares of Intuitive Surgical stock in a transaction on Friday, January 26th. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70. Following the sale, the executive vice president now directly owns 189 shares of the company’s stock, valued at approximately $69,958.35. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock valued at $95,927,097 over the last quarter. Company insiders own 0.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Stifel Nicolaus lifted their target price on Intuitive Surgical from $420.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, April 8th. BTIG Research upped their price objective on shares of Intuitive Surgical from $412.00 to $421.00 and gave the stock a “buy” rating in a report on Friday. Piper Sandler increased their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a research report on Friday. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday. Finally, Robert W. Baird decreased their price objective on shares of Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $381.24.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.